Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free:

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site:, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Google Analytics

Targeted advertising cookies


The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at or by post at:

24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal NutriNeurO logo partenaire Logo Bx INP

NutriNeuro: Integrated Nutrition and Neurobiology Lab

Zone de texte éditable et éditée et rééditée

Financial support of Optonutrics phase 2 obtained by Clémentine Bosch-Bouju

Financial support of Optonutrics phase 2 obtained by Clémentine Bosch-Bouju
By Bordeaux University

Clémentine Bosch-Bouju has obtained a financial support for Optonutrics project phase 2 by Idex (100 k€/2 years).

Objective of the Emergence Program: To recognize and support the development of dynamic emerging scientific trends based on a top-level research project and with high potential influence on the scientific field. This program is targeting researchers aiming at being involved in an original, creative approach with a degree of risk-taking in a pivotal consolidation period during their career.

Abstract: Optonutrics is a developing tool in the field of neuroscience, for the remote delivery of nutrients and other bioactive molecules in the brain in vivo, with high control in space, time and concentration. Bordeaux Emergence Phase 1 funding (2018-2021) allowed the development of photoactivable polymersomes that are biocompatible for brain applications. Phase 2 Bordeaux Emergence funding will be used to optimise the use of the photoactivable polymersomes in vivo, (ii) to apply it to basic research, related to Parkinson’s disease pathophysiology, and (iii) to develop it for clinical research. Optonutrics aims to become a powerful tool to decipher basic neurobiological processes and to pave the way to new therapeutics for neurological diseases.

Collaborators : Pierre Trifilieff (NutriNeuro), Sébastien Lecommandoux (LCPO, Bordeaux), Nathan McClenaghan (ISM, Bordeaux)